Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CVS Health ( (CVS) ) has shared an update.
At its May 14, 2026 annual meeting, CVS Health stockholders approved a new 2026 Incentive Compensation Plan to replace the expiring 2017 plan, with the new framework applying to awards granted after that date and reinforcing the company’s long‑term executive and employee incentive structure. The meeting reached quorum with more than 1.14 billion shares represented, signaling broad investor engagement in governance and compensation decisions.
Shareholders elected 13 directors to one‑year terms, ratified Ernst & Young LLP as the independent auditor for 2026, and backed the advisory vote on executive pay, underscoring support for current leadership and governance practices. Investors also rejected a shareholder proposal to lower the threshold for acting by written consent, preserving the existing balance of stockholder rights and potentially limiting activist leverage in corporate decision‑making.
The most recent analyst rating on (CVS) stock is a Buy with a $106.00 price target. To see the full list of analyst forecasts on CVS Health stock, see the CVS Stock Forecast page.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Neutral.
The score reflects stable fundamentals driven by solid cash generation and manageable (improving) leverage, but it is held back by sharply weaker margins and returns. Valuation is a clear positive with a low P/E and a moderate dividend yield. Technically, the trend is strong, though overbought readings increase near-term pullback risk. The latest earnings call is supportive due to raised EPS and cash flow guidance, tempered by medical cost, segment margin pressure, and timing-related volatility.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
CVS Health is a U.S. health care company operating across pharmacy, retail health, and insurance segments, providing prescription services, managed care, and related health solutions. The company targets consumers, employers, and government payers through integrated offerings that span pharmacies, health clinics, and health insurance plans.
Average Trading Volume: 8,154,779
Technical Sentiment Signal: Buy
Current Market Cap: $122.3B
Learn more about CVS stock on TipRanks’ Stock Analysis page.